Treace Medical Concepts, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Treace Medical Concepts, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-2.4×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 59% of Healthcare companies in United States.
Cash Locked Ratio
$34For every $100 of sales, $34 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $28 tied up three years earlier.
More money tied up than 73% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Less steady than 51% of Healthcare companies in United States.
Growth Efficiency Ratio
−$23Sales grew 50% in 3 years, but profit fell: $23 less profit per $100 of extra sales.
Lower than 78% of Healthcare companies in United States.
Asset Productivity Ratio
+50% / +20%In 3 years sales changed by +50% while total assets changed by +20%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-9.2×Operating cash was negative last year, while some debt falls due within a year.
Higher than 55% of Healthcare companies in United States.
Cash Cushion Ratio
−8%Debt, after subtracting cash, equals 8% of its market value (net debt).
Lower than 78% of Healthcare companies in United States.
Tangible Assets Ratio
90%Of every $100 the company owns, $90 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 61% of Healthcare companies in United States.
Tangible Net Worth Ratio
77%Of every $100 of net worth, $77 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 60% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Treace Medical Concepts, Inc. made a loss over the last year. Treace Medical Concepts, Inc. owes $0.63 for every $1 it owns. Treace Medical Concepts, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTreace Medical Concepts, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.11The share price is 4.11 times Treace Medical Concepts, Inc.'s book value per share, higher than 67% of Healthcare companies in United States.
Market cap
$278 MThe total market value of all of Treace Medical Concepts, Inc.'s shares at today's price (share price × number of shares), smaller than 53% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$68 MWhat Treace Medical Concepts, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.04Net worth divided by the number of shares. The share price of $4.28 is 4.1 times this, which is the P/B above.
Return on equity (ROE)
-72.0%Treace Medical Concepts, Inc. lost 72.0% of its shareholders' money over the last year, lower than 62% of Healthcare companies in United States.
Owes vs Owns
0.63×Treace Medical Concepts, Inc. owes $0.63 for every $1 it owns (moderate), higher than 66% of Healthcare companies in United States.
Dividend yield
NoneTreace Medical Concepts, Inc. does not currently pay a dividend.
Revenue growth
+2%Revenue rose 2% in the year to Dec 2025, and grew 14% a year on average over 3 years.
Profit growth
LossTreace Medical Concepts, Inc. made a loss in each of the last two years.
Profit margin
-27.7%Treace Medical Concepts, Inc. lost $28 for every $100 of revenue.
Interest cover
Not coveredTreace Medical Concepts, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtTreace Medical Concepts, Inc. had $23 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Treace Medical Concepts, Inc.: $278 M ÷ $68 M (30 Jun 2026) = 4.1.
What is Treace Medical Concepts, Inc.'s return on equity?
Treace Medical Concepts, Inc. lost 72.0% of its shareholders' money over the last year, lower than 62% of Healthcare companies in United States.
How much does Treace Medical Concepts, Inc. owe compared with what it owns?
Treace Medical Concepts, Inc. owes $0.63 for every $1 it owns (moderate), higher than 66% of Healthcare companies in United States.
Does Treace Medical Concepts, Inc. pay a dividend?
No. Treace Medical Concepts, Inc. does not currently pay a dividend.
Is Treace Medical Concepts, Inc.'s revenue growing?
Revenue rose 2% in the year to Dec 2025, and grew 14% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.